ACHV · Achieve Life Sciences Inc
United States · RS rating 81 · As of 2026-11-03
| Price | 6.73 USD |
|---|---|
| 1-day change | +1.8% |
| RS rating (overall / 1M / 3M / 12M) | 81 / 47 / 69 / 76 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 37 / 48 / 37 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +0.0% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +21.1% |
| Market cap (USD) | $220.9M |